Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
iReprogram
AddedFeb 15, 2024
UpdatedJun 18, 2026
iReprogram

iReprogram

Angel

iReprogram: Advancing personalized medicine through innovative cell regeneration research.

HQ
Ann Arbor, MI, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

iReprogram, founded with the mission to advance personalized medicine, focuses on innovative cell regeneration research. The company aims to expedite the delivery of next-generation treatments by leveraging cutting-edge technology and scientific breakthroughs. iReprogram's core services include developing regenerative therapies tailored to individual patient needs, targeting a market that spans healthcare providers, research institutions, and biotech firms seeking advanced medical solutions.

Notable figures affiliated with iReprogram include leading scientists and industry experts in regenerative medicine. The company has attracted significant investment from venture capital firms specializing in biotech innovations. Key achievements include pioneering new techniques in cell regeneration and forming strategic partnerships with top-tier medical institutions. iReprogram's impact is seen in its contributions to personalized healthcare, offering promising advancements in treatment efficacy and patient outcomes.

iReprogram - Similar Companies

Cell Reprogramming & Therapeutics logo

Cell Reprogramming & Therapeutics

Regenevida logo

Regenevida

recombinetics.com

InGeneron logo

InGeneron

ingeneron.com

Spheringenics logo

Spheringenics

ReLive logo

ReLive

relivebio.com

Regennova logo

Regennova

regennova.com

Rejuvitas logo

Rejuvitas

rejuvitas.com

Altos Labs logo

Altos Labs

altoslabs.com

Convalesce logo

Convalesce

convalesce.co

HebeCell logo

HebeCell

hebecellcorp.com

Regenemed logo

Regenemed

regenemed.com

NewLimit logo

NewLimit

newlimit.com

Endogena Therapeutics logo

Endogena Therapeutics

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Cellino logo

Cellino

cellinobio.com

iReprogram - Quick Facts

Who are iReprogram's competitors?

Companies similar to iReprogram include Cell Reprogramming & Therapeutics, Regenevida, InGeneron and Spheringenics.

When was iReprogram founded?

iReprogram was founded in 2017.

Where is iReprogram's headquarters located?

iReprogram's headquarters is located in Ann Arbor, MI, US.

When was iReprogram's last funding round?

iReprogram's most recent funding round was for $256k (USD) in February 2021.

How much has iReprogram raised to-date?

As of Feb 5, 2021, iReprogram has raised a total of $1.4M (USD).

How many employees does iReprogram have?

iReprogram has 5 employees as of Feb 4, 2024.

iReprogram - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Cell Regeneration
Tags
  • Consulting
  • Healthcare
  • Healthtech
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research